Suppr超能文献

(前)肾素受体作为心脏肾脏疾病的药理学靶点。

The (pro)renin receptor as a pharmacological target in cardiorenal diseaes.

机构信息

CCR Pharma (CCRP) Therapeutics, Berlin, Germany.

CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.

出版信息

Hypertens Res. 2023 Nov;46(11):2527-2534. doi: 10.1038/s41440-023-01424-6. Epub 2023 Sep 4.

Abstract

The (pro)renin receptor ((P)RR) is not only a member of the renin-angiotensin system (RAS) but also exerts several RAS-independent functions due to its multiple signal transductions pathways. In this mini-review, we shortly discuss the molecular functions of this receptor and its pathophysiological significance with a focus on cardiorenal diseases. Finally, we provide a short summary regarding a drug discovery and drug development program on small molecule-based renin/ prorenin receptor blockers (RERBs).

摘要

(前)肾素受体((P)RR)不仅是肾素-血管紧张素系统 (RAS) 的成员,还由于其多种信号转导途径而发挥多种 RAS 独立的功能。在这篇迷你综述中,我们简要讨论了该受体的分子功能及其在心肾疾病中的病理生理意义。最后,我们就基于小分子的肾素/(前)肾素受体阻滞剂 (RERBs) 的药物发现和药物开发计划提供了简短的总结。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验